Market Insights Health Hospitals Inpatient Care

Gastroenterology - Asia

Asia

The Gastroenterology market in Asia is expected to witness significant growth in the coming years.
According to projections, the revenue in this market is set to reach US$61.71bn by 2024.
Furthermore, a steady annual growth rate (CAGR 2024-2029) of 4.05% is anticipated, leading to a market volume of US$75.26bn by 2029.
When compared globally, it is worth noting that in the United States will contribute the most to the overall revenue in the Gastroenterology market.
In 2024, in the United States alone is projected to generate US$60,480.00m.
This signifies the prominence of the United States in terms of market size and opportunity within the Gastroenterology market.
In Asia, the gastroenterology market is witnessing a surge in demand for minimally invasive procedures in Japan.

Key regions: Brazil, China, Europe, United Kingdom, Canada

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.